Moderna, Inc. is a pioneering biotechnology company at the forefront of messenger RNA (mRNA) therapeutics and vaccines. Founded in 2010, the company's core mission is to create a new class of transformative medicines for patients by leveraging its proprietary mRNA technology platform. While widely recognized for its highly effective COVID-19 vaccine, Moderna's pipeline extends to a broad range of infectious diseases, oncology, cardiovascular diseases, and rare genetic disorders. Positioned as a leader in mRNA innovation, Moderna is rapidly advancing its technology to address significant unmet medical needs globally, establishing itself as a key player in the biopharmaceutical and vaccine industries.
Through the GEO Score system, we have measured Moderna's search visibility on the all AI platforms model.Current GEO Score is 99.0.
Audit Keyword：Moderna
Dimension Data Details
Moderna's Share of Model (SOM) is 100, higher than 20.0% of competitors
Moderna's Ranking is 95, higher than 70.0% of competitors
Moderna's Sentiment is 100, higher than 15.0% of competitors
Moderna's Accuracy is 100, higher than 5.0% of competitors
Moderna's Citation is 100, higher than 95.0% of competitors
Share of Voice (SoV)
Your brand's voice share compared to competitors in AI search
Improvement Opportunities
Your brand outperforms competitor averages across all dimensions
Competitor Comparison
| Brand | GEO Score | SOM | Ranking | Citation | Sentiment | Accuracy | View |
|---|---|---|---|---|---|---|---|
| Moderna(Current) | 99.0 | 100.0 | 95.0 | 100.0 | 100.0 | 100.0 | |
| BioNTech | 95.0 | 100.0 | 78.0 | 100.0 | 100.0 | 100.0 | View |
| Pfizer | 94.0 | 100.0 | 100.0 | 70.0 | 100.0 | 100.0 | View |
| Roche | 94.0 | 100.0 | 93.0 | 80.0 | 100.0 | 100.0 | View |
| AbbVie | 94.0 | 100.0 | 100.0 | 70.0 | 100.0 | 100.0 | View |
| WAI YUEN TONG | 94.0 | 100.0 | 100.0 | 70.0 | 100.0 | 100.0 | View |